Exhibit 10.2
SECOND AMENDMENT TO SUBLEASE
THIS SECOND AMENDMENT TO SUBLEASE (this “Amendment”) is made as of June 21, 2024 by and between BigHat Biosciences, Inc., a Delaware corporation (“Sublessor”) and Cargo Therapeutics, Inc. (formerly known as Syncopation Life Sciences, Inc.), a Delaware corporation (“Sublessee”), with reference to the following facts and objectives:
RECITALS
A. Sublessor, as tenant, and BP3-SF6 1900 ADLP LLC, as landlord (“Master Lessor”), are parties to that certain Lease dated as September 3, 2021, as amended by that certain First Amendment to Lease dated August 19, 2022 (as amended, the “Master Lease”), with respect to premises currently consisting of approximately 31,117 rentable square feet located on the third (3rd) floor (the “3rd Floor Premises”) and approximately 33,008 rentable square feet located on the fourth (4th) floor of the building located at 1900 Alameda de las Pulgas, San Mateo, California (the “Building”).
B. Sublessor and Sublessee are parties to a Sublease dated November 4, 2021 (the “Sublease”), with respect to a portion of the 3rd Floor Premises consisting of approximately 15,400 rentable square feet (the “Original Subleased Premises”), as amended by that certain First Amendment to Sublease dated August 17, 2022 (the “First Amendment”) wherein the premises subleased under the Sublease were expanded to include the remainder of the 3rd Floor Premises (the “Expansion Subleased Premises”).
C. Sublessor and Sublessee desire to terminate the Sublease with respect to the Expansion Subleased Premises and further modify the Sublease as set forth herein.
AGREEMENT
NOW, THEREFORE, in consideration of good and valuable consideration, the sufficiency of which is hereby acknowledged, the parties hereto agree as follows:
4870-4476-1289v.1
-2-
4870-4476-1289v.1
[SIGNATURES ARE ON THE FOLLOWING PAGE]
SUBLESSOR: SUBLESSEE:
BIGHAT BIOSCIENCES, INC., CARGO THERAPEUTICS, INC.,
a Delaware corporation a Delaware corporation
By: /s/ Mark DePristo By: /s/ Anup Radhakrishnan
Name: Mark DePristo Name: Anup Radhakrishnan
Its: CEO Its: Chief Financial Officer
-3-
4870-4476-1289v.1